This website uses cookies ðŠ
We use cookies to ensure you get the best online experience. For more details, please see our Privacy and Cookie Policy. Read more.
ECMO (Extracorporeal Membrane Oxygenation) is a vital technology that temporarily takes over the function of the heart and lungs. It's used when these organs fail due to conditions like myocarditis, coronary artery disease, or severe acute respiratory distress syndrome, particularly when standard treatments are ineffective. ECMO provides crucial support, allowing the heart and lungs time to heal or recover.
The ECMO machine acts as an artificial heart, pumping blood, and an artificial lung, exchanging oxygen and carbon dioxide. Deoxygenated blood is drawn from the patient via a cannula, oxygenated by the machine, and then returned to the patient's body. This process is similar to the heart-lung bypass machine used during cardiac surgery.
ECMO is indicated for patients experiencing:
Heart and lung failure can result from underlying diseases or occur as complications following cardiac procedures or surgery.
Complications associated with ECMO may include:
Patients requiring ECMO have an average survival rate of approximately 50% (according to ELSO data).
ECMO support can be discontinued, and the cannulae removed, when the heart and lungs recover to near-normal or normal function.
Information by:
Assoc. Prof. Seri Singhathana Kit, M.D.